Stay updated on Pembrolizumab + Palliative Radiotherapy in BC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab + Palliative Radiotherapy in BC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab + Palliative Radiotherapy in BC Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    Change Detected
    Summary
    The clinical trial record for pembrolizumab plus palliative radiotherapy in metastatic breast cancer is now displayed instead of an access-denied error. It includes study design, eligibility, outcomes, and the update that the trial terminated at stage 1 for lack of evidence of promise.
    Difference
    51%
    Check dated 2026-11-09T14:47:16.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov site revision shown in the footer changed from v3.7.2 to v3.8.0; the page still displays a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-11-02T16:26:08.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    A site-wide NIH banner announces a terminology transition from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-26T14:52:21.000Z thumbnail image
  5. Check
    28 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page remains a 403 Forbidden error page, with its footer revision label changing from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-19T14:42:50.000Z thumbnail image
  6. Check
    35 days ago
    Change Detected
    Summary
    The revision identifier in the footer changed from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-12T15:43:36.000Z thumbnail image
  7. Check
    49 days ago
    Change Detected
    Summary
    A 403 Forbidden error is shown when attempting to access the study record, replacing the usual page content with an access-restricted screen and standard site chrome.
    Difference
    0.5%
    Check dated 2026-09-28T17:14:37.000Z thumbnail image

Stay in the know with updates to Pembrolizumab + Palliative Radiotherapy in BC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Palliative Radiotherapy in BC Clinical Trial page.